Dr Hollands trained with Professor R. G. Edwards FRS at Cambridge University in the area of embryonic stem cells. On being awarded a PhD in Stem Cell Biology, Dr Hollands became an academician and researcher at Anglia Ruskin University in Cambridge, teaching in medical sciences and carrying out research in the field of stem cell biology.
In 2003, Dr Hollands was appointed as the Scientific Director for Cells for Life a Private Cord Blood Bank in Canada. Later in 2006, he was the Chief Scientific Officer for UK Cord Blood Bank (UK CBB) where he was the designated individual responsible for UK CBB under the Human Tissue Authority license. In year 2007, he was appointed Senior Scientist of Novathera Ltd, a leading stem cell company in the UK. His role is to develop stem cell technology and IP within the company with an emphasis novel cord blood stem cell expansion technology in collaboration with Imperial College London and to take this technology to market.
His also specializes in the area of haemopoietic and epidermal stem cells. His major research interest was in the differentiation and developmental biology of stem cells, especially those of the haemopoietic, epidermal and central nervous systems. He was also particularly interested in the developmental biology of embryonic stem cells. He also has experience in haematology and transfusion, clinical chemistry, medical microbiology and cellular pathology through Papworth, Newmarket and Addenbrokke’s Blood Transfusion Centre.
Dr Hollands is a member of International Society of Stem Cell Research. He has numerous publications to his credit on the subject of stem cells and clinical embryology and he sits on various advisory boards and as well as being a consultant to several companies.